JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1083/jcb.200706152
The Journal of Cell Biology, Vol. 181, No. 6, 945-957
The Rockefeller University Press, 0021-9525 $30.00
© Tian et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4188K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, Y.
Right arrow Articles by Jackowski, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, Y.
Right arrow Articles by Jackowski, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Cytokine secretion requires phosphatidylcholine synthesis



Yong Tian1, Caroline Pate1, Alberto Andreolotti1,3, Limin Wang1, Elaine Tuomanen1, Kelli Boyd2, Enrique Claro3, and Suzanne Jackowski1

1 Department of Infectious Diseases and 2 Animal Resource Center, St. Jude Children's Research Hospital, Memphis, TN 38105
3 Institut de Neurociències i Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain

Correspondence to Suzanne Jackowski: suzanne.jackowski{at}stjude.org

Choline cytidylyltransferase (CCT) is the rate-limiting enzyme in the phosphatidylcholine biosynthetic pathway. Here, we demonstrate that CCT{alpha}-mediated phosphatidylcholine synthesis is required to maintain normal Golgi structure and function as well as cytokine secretion from the Golgi complex. CCT{alpha} is localized to the trans-Golgi region and its expression is increased in lipopolysaccharide (LPS)-stimulated wild-type macrophages. Although LPS triggers transient reorganization of Golgi morphology in wild-type macrophages, similar structural alterations persist in CCT{alpha}-deficient cells. Pro–tumor necrosis factor {alpha} and interleukin-6 remain lodged in the secretory compartment of CCT{alpha}-deficient macrophages after LPS stimulation. However, the lysosomal-mediated secretion pathways for interleukin-1β secretion and constitutive apolipoprotein E secretion are unaltered. Exogenous lysophosphatidylcholine restores LPS-stimulated secretion from CCT{alpha}-deficient cells, and elevated diacylglycerol levels alone do not impede secretion of pro–tumor necrosis factor {alpha} or interleukin-6. These results identify CCT{alpha} as a key component in membrane biogenesis during LPS-stimulated cytokine secretion from the Golgi complex.

Y. Tian and C. Pate contributed equally to this paper.

L. Wang's present address is Department of Internal Medicine, University of California, Davis, Davis, CA 95616.

Abbreviations used in this paper: ApoE, apolipoprotein E; CCT, cytidylyltransferase; CDP–Cho, cytidine diphosphocholine; C/EPT, choline/ethanolamine phosphotransferase; CPT, choline phosphotransferase; ERGIC-53, ER–Golgi intermediate compartment 53-kD protein; edelfosine, Et-18-OCH3; fMLP, formyl-methionylleucylphenylalanine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IL-1β, interleukin-1β; IL-6, interleukin-6; LCM, L cell–conditioned medium; LPS, lipopolysaccharide; lysoPC, lysophosphatidylcholine; PEMT, phosphatidylethanolamine methyltransferase; PGE2, prostaglandin E2; PLD1, phospholipase D1; pro-TNF{alpha}, precursor form of TNF{alpha}; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; PtdOH, phosphatidic acid; P'tse, phosphatase; qRT-PCR, quantitative RT-PCR; SM, sphingomyelin; TAPI, N-(D,L-[2-(hydroxyaminocarbonyl)methyl]-4-methylpentanoyl)-L-3-(2'naphthyl)-alanyl-L-alanine, 2-aminoethylamide; TACE, TNF{alpha}-converting enzyme.

© 2008 Tian et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents